Clinical Trial Update: Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating persistence of immunity against Hepatitis B in adolescents aged 12-13 years who were vaccinated in infancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GlaxoSmithKline Hepatitis B vaccine (infant vaccination program)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2011-03-01